Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
Modern Chinese Medicine Group Co. Ltd. ( (HK:1643) ) just unveiled an announcement.
Modern Chinese Medicine Group Co., Ltd. has warned investors that it expects to swing to a net loss of at least RMB13 million for the year ended 31 December 2025, compared with a net profit of about RMB9.7 million a year earlier. The company attributes the deterioration mainly to the loss of some distributors, the removal of certain best-selling products from the national medical insurance list, reduced purchase orders that kept unit fixed costs high, and margin pressure from price reductions on products that remain reimbursable.
The announcement underscores mounting headwinds for traditional Chinese medicine manufacturers amid ongoing medical insurance reforms in mainland China, which can quickly alter demand for reimbursed products. Investors are cautioned that the figures are based on unaudited management accounts and may change when the full-year results are released by the end of March 2026, but the guidance already signals a weaker earnings outlook and potential pressure on the group’s share price.
The most recent analyst rating on (HK:1643) stock is a Hold with a HK$0.91 price target. To see the full list of analyst forecasts on Modern Chinese Medicine Group Co. Ltd. stock, see the HK:1643 Stock Forecast page.
More about Modern Chinese Medicine Group Co. Ltd.
Modern Chinese Medicine Group Co., Ltd. is a Hong Kong-listed manufacturer of traditional Chinese medicine products. The group focuses on prescription and over-the-counter formulations, with key offerings such as Cardiotonic Enhancement Capsule previously benefiting from inclusion in China’s national medical insurance list, giving it access to the broader domestic healthcare market.
Average Trading Volume: 2,424,293
Technical Sentiment Signal: Buy
Current Market Cap: HK$1.18B
Learn more about 1643 stock on TipRanks’ Stock Analysis page.